Jayden on for Rachel Battenslow's questions to Twist Bioscience Corp (TWST) leadership • Q3 2025
Question
Representing Rachel Battenslow, Jayden asked for the reason behind the Synbio revenue shortfall for the quarter compared to the original guidance of $37 million to $39 million.
Answer
CEO & Co-Founder Dr. Emily Leproust attributed the variance to a difficult year-over-year comparison caused by a large, non-recurring order from a contracted customer in the prior year. She explained that while the company successfully added hundreds of new, smaller customers, there was some uncertainty in their initial ramp-up speed. Excluding the tough comparison, the underlying Synbio business grew over 20%.